Quest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference



SECAUCUS, N.J., Dec. 21, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance, and the latest market developments and trends during a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024, at 6:45 p.m. Eastern Time.

The fireside chat and Q&A session will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 8, 2024.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

Cision View original content to download multimedia:

SOURCE Quest Diagnostics

Company Codes: NYSE:DGX

Back to news